2023 annual financial data
ABVC BioPharma 2023 Operating margin
Direct answer
Operating margin was -4,439.24%.
Operating income was -6,766,734 USD and net income was -7,788,050 USD.
Operating cash flow was -4,186,848 USD.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,430 USD
- Operating income
- -6,766,734 USD
- Net income
- -7,788,050 USD
- Operating cash flow
- -4,186,848 USD